Send me a link:

*Text messaging rates may apply.

 Dow Down 0.32% Nasdaq Down 0.51%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NCM
1.48 Down 0.03(1.99%) 11:34AM EDT - Nasdaq Real Time Price
Prev Close:1.51
Open:1.52
Bid:1.48 x 45500
Ask:1.49 x 3300
1y Target Est:4.17
Beta:0.6
Earnings Date:Sep 8 - Sep 12 (Est.)
Day's Range:1.48 - 1.52
52wk Range:1.16 - 3.18
Volume:394,576
Avg Vol (3m):1,234,540
Market Cap:265.23M
P/E (ttm):N/A
EPS (ttm):-0.22
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PPHM

Comparison

Symbol% ChgMkt Cap
PPHMDown 1.99%265.23M
AMGNDown 1.13%95.60B
NVSUp 0.12%211.18B
RHHBYDown 0.23%246.25B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Apr-15) :-0.27
Quarterly EPS Est (Jul-14) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the research and development of novel monoclonal antibodies for the treatment and diagnosis of cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback